Back to results
US 2013/0096020 A1Published application
Generation of binding molecules
AssigneeMerus Biopharmaceuticals B.V.
InventorsMark THROSBY, Ton LOGTENBERG, John De KRUIF
Life of this patent
Estimating the term…
Abstract
Provided are methods for efficiently and comprehensively screening antibody repertoires from B cells to obtain and produce molecules with binding characteristics and functional activities for use in human therapy.
Claims20
A method for producing a defined population of binding molecules, said method comprising:
- a) providing a population of B cells expressing a limited VL repertoire wherein essentially all of said B cells carry at least one VL,
- b) obtaining nucleic acids from said B cells,
- c) obtaining sequences of essentially all obtained nucleic acids of step b),
- d) performing a frequency analysis of the sequences from step c),
- e) selecting desired VH sequences,
- f) providing a host cell with at least one vector comprising at least one of said desired VH sequences and/or at least one VL sequence of said limited VL repertoire,
- g) culturing said host cells and allowing for expression of VH and/or VL polypeptides, and
- h) obtaining said binding molecules.
5 more elements
Dependencies are inferred from the claim text.